ISO/TC 212
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 71293 | ISO 35001:2019 | Biorisk management for laboratories and other related organisations | Standarts spēkā |
| 88418 | ISO 35001:2019/Amd 1:2024 | Biorisk management for laboratories and other related organisations — Amendment 1: Climate action changes | Standarts spēkā |
| 81506 | ISO 5649:2024 | Medical laboratories — Concepts and specifications for the design, development, implementation and use of laboratory-developed tests | Standarts spēkā |
| 93490 | ISO/AWI 20776-1 | Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | Izstrādē |
| 93491 | ISO/AWI 35001 | Biorisk management for laboratories and other related organisations | Izstrādē |
| 85074 | ISO/AWI TS 17849 | Guidance on the validation and verification of quantitative and qualitative methods | Izstrādē |
| 86743 | ISO/AWI TS 20776-3 | ISO/TS 20776-3, Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — — Part 3: Part 3: Quality performance of disc-diffusion agar method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases | Izstrādē |
| 91317 | ISO/AWI TS 25725 | Design and workflow requirements for in vitro diagnostics NGS based oncology application | Izstrādē |
| 26308 | ISO/CD 15196 | Identification and determination of analytical and clinical performance goals for laboratory methodologies | Izstrādē |
| 91142 | ISO/CD 15197 | In vitro diagnostic test systems — Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus | Izstrādē |
Displaying 61-70 of 146 results.